Your Messages Inbox
Your Article Summary
See Latest ArticlesBig Pharma isn't dead, but long live small pharma
PharmExec, 07/15/09
Everyone knows that life is tough in the world of Big Pharma. And, in Europe, it's getting tougher every day. The most immediate blow is the threat that hangs over the scope for patent protection for blockbusters, as the dust settles from the European Commission's inquiry into competition in the sector (the EC's report on this is scheduled for release as this issue of Pharm Exec Europe hits your inbox.) The inquiry has cast a shadow over how far innovators can legitimately go in using their intellectual property rights to protect their blockbusters against generic erosion.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09
Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Amgen, 12/08/09
Article Search
Sponsor